BSX:NYSE
Boston Scientific Corp
$45.40
arrow_upward
+0.77%(+0.35) 1D
Oct 20, 1:44:04 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSX...
Open
$45.67
High
$46.04
Low
$45.15
Mkt. cap
65.83B
Avg. vol.
19.15M
Volume
8.15M
P/E ratio
18.42
52-wk high
$105.65
52-wk low
$41.38
EPS
$2.47
Beta
0.58
Shares outstanding
1.45B
No. of employees
59K
Open
$45.67
High
$46.04
Low
$45.15
Mkt. cap
65.83B
Avg. vol.
19.15M
Volume
8.15M
P/E ratio
18.42
52-wk high
$105.65
52-wk low
$41.38
EPS
$2.47
Beta
0.58
Shares outstanding
1.45B
No. of employees
59K
News stories
From web sources and news partners
Investing.com
·
3 hours ago
TD Cowen reiterates Boston Scientific stock rating on 2027 outlook
ad-hoc-news.de
·
3 hours ago
Boston Scientific stock: Leerink cuts target to USD 55.00 from USD 60.00
The Business Journals
·
8 hours ago
Boston Scientific CEO sees 'clear way out' of 2026 challenges amid cyberattack, investor pressure
ad-hoc-news.de
·
8 hours ago
Boston Scientific appoints COO. Boston Scientific stock costs EUR 40.33 at USD 65.3 billion value
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries.
BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp
CEOMichael F. Mahoney
Employees59K
FoundedJun 29, 1979
HeadquartersMarlborough, Massachusetts, United States
SectorMedical device
Websitebostonscientific.com